ID
20416
Beschrijving
Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00536939
Link
https://clinicaltrials.gov/show/NCT00536939
Trefwoorden
Versies (1)
- 22-02-17 22-02-17 -
Geüploaded op
22 februari 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00536939
Eligibility Breast Cancer NCT00536939
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
cns metastases
Datatype
boolean
Alias
- UMLS CUI [1]
- C0686377
Beschrijving
have a history of seizure
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0036572
- UMLS CUI [1,2]
- C0262926
Beschrijving
surgical procedure
Datatype
boolean
Alias
- UMLS CUI [1]
- C0543467
Beschrijving
Minor Surgical Procedures | Vascular Access Device Placement | Fine needle aspiration biopsy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0038904
- UMLS CUI [2]
- C1519955
- UMLS CUI [3]
- C1510483
Beschrijving
symptomatic peripheral vascular disease
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0085096
- UMLS CUI [1,2]
- C0231220
Similar models
Eligibility Breast Cancer NCT00536939
- StudyEvent: Eligibility
C0679557 (UMLS CUI [1,2])
C1298647 (UMLS CUI [1,3])
C1336869 (UMLS CUI [2])
C0277556 (UMLS CUI [3])
C2939420 (UMLS CUI [4])
C2986682 (UMLS CUI [2])
C2939420 (UMLS CUI [3])
C0600558 (UMLS CUI [1,2])
C0677850 (UMLS CUI [1,3])
C1514457 (UMLS CUI [1,4])
C0021430 (UMLS CUI [2])
C0262926 (UMLS CUI [1,2])
C1519955 (UMLS CUI [2])
C1510483 (UMLS CUI [3])
C0231220 (UMLS CUI [1,2])